Navigation Links
VIC Investor Network to Significantly Accelerate Technology Company Growth
Date:2/23/2013

Fayetteville, AR (PRWEB) February 22, 2013

Yesterday, Calvin Goforth, Chief Executive Officer and Founder of VIC Technology Venture Development™ (VIC™), announced the formation of the VIC Investor Network, a new fund that will significantly accelerate and expand technology venture development in Arkansas. The VIC Investor Network will place $250,000 start-up capital into every new portfolio company that VIC forms. Start-up capital is the most difficult funding to acquire. The VIC Investor Network funding will allow VIC to jumpstart its new portfolio companies and significantly shorten the average company development time.

Dr. Goforth made the announcement at VIC’s offices, following a presentation by Mitch Horowitz, Vice President & Managing Director of Battelle Technology Partnership Practice of Cleveland, Ohio. Mr. Horowitz led an in-depth 2012 Battelle study entitled Arkansas' Knowledge Economy Initiatives. He spoke about the importance of technology based economic development for Arkansas’ future economy, the benefits of the state’s incentive programs for encouraging such development, and he introduced the unique role VIC plays: “VIC fills key challenges and gaps for technology based economic development efforts by bringing together the initial management, product development, business development, and administrative teams needed to launch successful companies based on university inventions.”

With the VIC Investor Network in place, VIC will now be adding four new companies to its portfolio each year. This is approximately triple VIC’s previous rate of expansion. VIC estimates that over 100 high paying jobs of the future will be created in VIC portfolio companies over the next 3 years. VIC will also be adding additional sites across the country as it has developed and proven a uniquely effective business model for translating university research into outstanding young technology companies.

Following today’s announcement, guests were able to interact with several VIC portfolio companies showcasing their new products and services, and meet the CEOs and teams advancing them. One company, Ascendant Diagnostics™, is developing a screening test to detect early-stage breast cancer with just a tear sample. Another, CardioWise™, is perfecting a single diagnostic test that will provide unprecedented information about heart health. Yet another, BioDetection Instruments™, has developed an instrument that provides rapid detection of bacteria and other contaminants in food, water, and beverages that is portable, easy to use, and reliable.

For the past nine years, VIC has been quietly building cutting-edge, world-class technology companies in fields ranging from nanotechnology and cancer diagnostics to pharmaceuticals and semiconductors in Northwest Arkansas. VIC has developed a unique business model for forming and developing companies based on licensed early stage technologies from top research universities across the country. Each year, over $60 billion dollars of funding goes into sponsored research at universities resulting in thousands of new inventions. Most of these technologies do not get commercialized because there is a significant gap between the stage at which larger companies will license a technology, or at which most venture capital firms will invest in a technology, and the stage to which the technologies are developed within a university.

VIC’s business model was specifically developed and optimized to fill this gap. VIC’s method of building companies using a shared resources model where technical, business, financial, and legal expertise are brought together, allows for lower costs and higher success rates. VIC has attracted world-class talent and multiple breakthrough products have been brought to market. Key achievements to date include:

  •     Twelve portfolio companies based on large market potential disruptive technologies
  •     Over $30MM in federal grant funding into portfolio since 2003
  •     Multiple innovative, large market opportunity products brought to market
  •     Average wage of about $90,000
  •     Rapid value growth in portfolio companies estimated at over 40% per year average
  •     Successfully translated VIC business model to Boston, MA area with opening of Atlantic VIC

The VIC Investor Network, combined with VIC’s unique business model for technology commercialization, is expected to facilitate unprecedented growth in science and engineering based technology enterprise development in Arkansas.

VIC Technology Venture Development, LLC is a technology venture development firm that creates innovative new companies with world changing science and engineering based technologies. VIC carefully selects and licenses technologies from universities and research institutions, then partners technology entrepreneurs with business experts, technology experts and seed stage investors. VIC provides its portfolio companies with senior management expertise, intimate knowledge of technology startups, and proven processes to execute business strategies. Its team members bring extensive experience across legal, financial, operations, marketing, capital acquisition, and technology management areas. VIC experts help their portfolio companies meet management and business planning goals by providing appropriate support at each stage in their development, only as it is needed.

###

Read the full story at http://www.prweb.com/releases/2013/2/prweb10459275.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PDL BioPharma to Present at Two Upcoming Investor Conferences
2. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
3. Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference
4. Palatin Technologies, Inc. to Present at 15th Annual BIO CEO & Investor Conference
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Neptune Technologies & Bioressources Inc. To Contact The Firm
6. EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York
7. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
8. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Luminex Corporation To Host Investor Event December 11, 2012
10. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
11. CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):